Loomis Group Health, Capella Advisors Form Strategic Partnership to Guide Healthcare Companies from Clinical Trials to Marketplace
Firms Provide End-to-End Commercialization and Marketing Services for Pharmaceutical, Biotech and Medical Device Companies
SAN FRANCISCO—Oct. 15, 2009—Loomis Group, an independent, integrated marketing agency, today announced a strategic partnership with Capella Advisors that will provide healthcare companies with strategic planning, commercialization expertise and innovative marketing programs for new products targeted at consumers.
Through the partnership, Loomis Group Health and Capella Advisors will offer pharmaceutical, biotech and medical device companies the full spectrum of services from planning and development in preparation for commercialization through marketing to consumers.
“This partnership takes a different approach to healthcare marketing. By linking business strategists and communications experts on one team, we will deliver more effective campaigns built on a deeper and broader knowledge base than traditional agency campaigns,” said Loomis Group CEO Jeff Loomis. “Integrating our teams also streamlines client programs, which is important in this economy.”
Capella Advisors is a multi-disciplinary group of professionals holding doctorate, medical, law and M.B.A. degrees, and brings several years of major strategy-?rm experience, including work at McKinsey & Co. Capella Advisors has consulted with the top 10 global pharmaceutical companies and has deep expertise in the fields of cardiovascular, oncology, urology, central nervous system, ophthalmology, HIV, contraception, sexual dysfunction, respiratory, general surgery, orthopedics and neurosurgery.
“This partnership is a timely and strategic response to the needs of healthcare companies that must address global competition, regulatory stringencies and rapidly evolving market demands,” said Rosina Samadani, Ph.D., CEO of Capella Advisors. “Capella Advisors and Loomis Group offer these companies proven and innovative services from the development phase to marketing to consumers, to help them achieve success.”
Loomis Group Health’s award-winning campaigns are rooted in pushing the boundaries within the typically traditional healthcare arena by cross-pollinating leading-edge marketing ideas gleaned from other market categories. The group was founded 10 years ago when an executive from Arterial Vascular Engineering (acquired by Medtronic) specifically sought an agency outside the traditional healthcare agency practice in search of fresher ideas. Loomis Group Health’s success with Arterial Vascular Engineering progressed to deep and broad marketing expertise in a variety of health needs and disease states such as: cardiology, renal disease, neurology, oncology, neuro-vascular, cosmetic/aesthetic, birth control, diabetes, gastrointestinal, chronic severe pain and ophthalmology. Clientele have included larger companies like Abbott, Elan Pharmaceuticals, Medtronic and Fresenius Medical Care North America, as well as rapidly growing companies like Solta Medical, makers of Fraxel and Thermage; and Conceptus, makers of the innovative Essure birth control procedure.
About Loomis Group Founded in 1987, Loomis Group is an independent, integrated marketing agency with offices and affiliates worldwide. The company energizes brands by inspiring people to change what they are doing, buying or thinking with strategic communication programs built to drive ideas through public relations, advertising, design and interactive channels. Headquartered in San Francisco, Loomis Group maintains offices in Boston and Paris and is supported by affiliates worldwide.
About Capella Advisors Capella Advisors was founded in 2004 by Rosina Samadani, Ph.D., a former McKinsey consultant. They are an experienced group of strategy consultants with deep knowledge of the healthcare industry. Headquartered in New York, with an office in San Francisco, they have done strategic work for clients in the U.S., EU and Japan from pre-commercialization to post-launch.
Posted: October 2009